NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
3.470
-0.090 (-2.53%)
Jun 3, 2026, 4:00 PM EDT - Market closed

NMTC Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
304431212747
Market Cap Growth
-9.09%45.66%43.18%-22.26%-42.23%66.22%
Enterprise Value
27.3138.0129.2416.0416.3840.74
Last Close Price
3.475.335.945.3410.1423.70
PS Ratio
2.353.678.836.2512.93195.26
PB Ratio
5.566.2837.113.412.857.24
P/TBV Ratio
5.385.0532.232.582.826.45
EV/Sales Ratio
2.153.148.474.717.73167.69
Debt / Equity Ratio
0.020.020.240.010.010.03
Net Debt / Equity Ratio
-0.50-0.91-1.54-0.84-1.15-1.02
Net Debt / EBITDA Ratio
0.401.620.110.451.110.66
Net Debt / FCF Ratio
0.362.200.110.401.410.77
Asset Turnover
1.181.500.510.330.200.04
Inventory Turnover
2.501.631.091.230.605.61
Quick Ratio
3.103.400.742.973.615.88
Current Ratio
4.384.442.094.083.936.17
Return on Equity (ROE)
-88.42%-91.34%-348.39%-149.61%-123.77%-230.81%
Return on Assets (ROA)
-85.95%-52.32%-176.53%-114.29%-96.63%-160.94%
Return on Invested Capital (ROIC)
-198.23%-234.23%-887.48%-775.25%-727.62%-873.16%
Return on Capital Employed (ROCE)
-104.72%-72.62%-251.28%-149.17%-121.73%-223.09%
Buyback Yield / Dilution
-67.85%-50.03%-47.69%-13.27%-49.56%-97.52%
Total Shareholder Return
-67.85%-50.03%-47.69%-13.27%-49.56%-97.52%
SEC Filings: 10-K · 10-Q